financetom
Business
financetom
/
Business
/
Dialysis giants DaVita and Fresenius Medical sued by employee benefits plan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dialysis giants DaVita and Fresenius Medical sued by employee benefits plan
May 26, 2025 6:07 AM

May 12 (Reuters) - A union health benefits fund has sued

top U.S. dialysis service providers DaVita ( DVA ) and Fresenius

Medical Care in federal court in Colorado for

allegedly conspiring to artificially inflate treatment costs by

billions of dollars.

The proposed nationwide class action was filed on Friday by

Pennsylvania-based United Food and Commercial Workers Local

1776, which provides benefits for thousands of members across

the United States.

DaVita ( DVA ) and Fresenius, the two largest dialysis providers in

the United States, illegally carved up areas in the country to

avoid competition, the lawsuit said.

The plaintiffs also said the companies since at least 2021

have engaged in parallel price increases that are higher than

competitors and "not adequately explained by market forces."

DaVita ( DVA ) in a statement on Monday said "the allegations in

this case are baseless, and we will defend against it

vigorously."

Fresenius declined to comment. Attorneys for United Food and

Commercial Workers Local 1776 did not immediately respond to

requests for comment.

German healthcare group Fresenius spun off Fresenius Medical

Care in 2023 and is not a defendant.

In the United States, DaVita ( DVA ) and Fresenius earn more than

90% of industry revenue for dialysis services, according to the

lawsuit. The complaint said the two companies acquired their

dominance through a "decades-long strategy of acquiring small,

independent clinics in uncontested mergers."

The lawsuit also alleged the two companies have had

opportunities to collude on pricing through their partnerships

and deals.

United Food and Commercial Workers Local 1776 pays for

dialysis services for its members. The lawsuit seeks class

status for all purchasers of outpatient dialysis services from

DaVita ( DVA ), Fresenius or one of their affiliates.

DaVita ( DVA ) is among a group of outpatient medical center

operators facing antitrust claims in the federal court in

Chicago, Illinois, over employee compensation and mobility.

The plaintiffs in that proposed class action, filed in 2021,

have alleged a conspiracy over hiring and recruitment practices

for senior employees at ambulatory surgery centers and

outpatient medical facilities suppressed pay.

An expert for the plaintiffs has estimated class-wide

damages of nearly $870 million in that case. DaVita ( DVA ) and the

other defendants in that lawsuit have denied any wrongdoing.

The case is United Food and Commercial Workers Local 1776

and Participating Employers Health and Welfare Fund v. DaVita

Inc ( DVA ) et al, U.S. District Court, District of Colorado, No.

1:25-cv-01478.

For plaintiffs: Stephen Tillery and Andrew Ellis of Korein

Tillery, Vincent Briganti of Lowey Dannenberg and Eric Young of

Young Law Group

For defendants: No appearance yet

Read more:

US drops antitrust case over healthcare hiring agreements

DaVita ( DVA ) loses bid to dismiss class 'no-poach' claims

DaVita ( DVA ) and its former CEO acquitted of U.S. antitrust

charges

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved